Patents by Inventor Rosa Lamarca Casado

Rosa Lamarca Casado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000517
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: May 11, 2021
    Assignee: Almirall, S.A.
    Inventors: Rosa Lamarca Casado, Gonzalo De Miquel Serra
  • Publication number: 20180303806
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
    Type: Application
    Filed: June 27, 2018
    Publication date: October 25, 2018
    Inventors: Rosa Lamarca CASADO, Gonzalo De Miquel SERRA
  • Patent number: 10085974
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: October 2, 2018
    Assignee: Almirall, S.A.
    Inventors: Rosa Lamarca Casado, Gonzalo De Miquel Serra
  • Publication number: 20170128426
    Abstract: A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.
    Type: Application
    Filed: January 19, 2017
    Publication date: May 11, 2017
    Inventors: Rosa LAMARCA CASADO, Gonzalo DE MIQUEL SERRA
  • Patent number: 9254262
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: February 9, 2016
    Assignee: Almirall, S.A.
    Inventors: Rosa Lamarca Casado, Gonzalo De Miquel Serra
  • Publication number: 20110020412
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
    Type: Application
    Filed: March 13, 2009
    Publication date: January 27, 2011
    Inventors: Rosa Lamarca Casado, Gonzalo De Miquel Serra
  • Publication number: 20110020454
    Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.
    Type: Application
    Filed: March 13, 2009
    Publication date: January 27, 2011
    Inventor: Rosa LAMARCA CASADO